# Phase 0 verification record — 2026-10-13

This is a documentation/contract baseline, NOT a functional ML application and NOT clinical validation.

## Repository audit

- Production `main` initially contained only `README.md`.
- Research `main` contained the inference/training/evaluation Python modules and notebooks.
- No .keras or label_map.json in tracked file trees on either default branch.
- Original research repository was read-only; no changes were made to it.

## Automated evidence

- Initial attempt failed Ruff import sorting; corrected in follow-up commit (record failure, do not hide it).
- Successful GitHub Actions contract CI, first passing baseline: https://github.com/shanmukhdatta/DermaLens-AI/actions/runs/38430143536
- Observed steps: checkout, Python setup, dependency install, Ruff lint, file/link/fence + JSON Schema + OpenAPI validation, four pytest contracts — passed.
- Tests: four passed. The first passing run had an OpenAPI validator deprecation warning; the validator import was subsequently updated to remove that warning. Check the latest branch run for final status.
- Connector-side independent check: 30 tracked files, 19 architecture markdown documents, five Mermaid code fences (flowchart/sequence), no detected broken relative links or unclosed fences at that commit.
- API and model schemas are structural, not evidence that requests or checkpoints work.

## Not run and not claimed

- Keras deserialization, custom-layer compatibility, artifact/checksum verification, model output parity, image processing, real/synthetic data metrics, end-to-end analysis, frontend, database, RAG provider calls, container builds and deployment.
- Mermaid engine rendering/semantic parsing (only fenced-diagram structure reviewed). Render diagrams during Phase 1 documentation tooling validation if possible.
- This workspace could not clone the repository directly due to blocked DNS. GitHub Actions executed the committed tests instead.
- Security penetration testing, performance/load, accessibility browser checks, data-protection/legal review, regulated-device evaluation.

## Release/phase blockers

Phase 0 has no model-dependency blocker. Phase 9 requires an authorized private .keras checkpoint and matching label_map.json plus exact production-compatible serialization/dependency metadata. Phase 10 requires appropriately consented/licensed real evaluation data. No new license has been chosen for DermaLens AI; decide and document the license before public distribution. Backend/frontend deployment and any medical claims remain forbidden until later phase gates.

## Status

**Implemented and CI-tested architecture baseline, pending PR review/merge and any further checks on updated commits.** Never mark runtime or clinical functionality complete based on this document.
